111, Inc. (NASDAQ:YI – Get Free Report) saw a large increase in short interest in October. As of October 15th, there was short interest totalling 74,600 shares, an increase of 82.0% from the September 30th total of 41,000 shares. Based on an average daily volume of 294,600 shares, the short-interest ratio is presently 0.3 days.
Institutional Trading of 111
An institutional investor recently bought a new position in 111 stock. Deuterium Capital Management LLC purchased a new stake in shares of 111, Inc. (NASDAQ:YI – Free Report) during the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm purchased 100,000 shares of the company’s stock, valued at approximately $116,000. Deuterium Capital Management LLC owned approximately 0.12% of 111 at the end of the most recent reporting period. Institutional investors own 21.32% of the company’s stock.
111 Trading Down 2.3 %
NASDAQ YI opened at $0.75 on Friday. The company has a fifty day simple moving average of $0.80 and a 200 day simple moving average of $1.00. 111 has a 12-month low of $0.55 and a 12-month high of $2.49. The company has a market cap of $64.31 million, a P/E ratio of -1.21 and a beta of 0.39.
About 111
111, Inc, together with its subsidiaries, operates an integrated online and offline platform in the healthcare market in the People's Republic of China. It operates through two segments, B2C and B2B. The company sells medical and wellness products through online retail, and wholesale and retail pharmacies, as well as provides value-added services that include online consultation services and electronic prescription services to consumers.
Further Reading
- Five stocks we like better than 111
- Election Stocks: How Elections Affect the Stock Market
- Lam Research Proves Analysts Wrong with a Strong Earnings Report
- What is the Nikkei 225 index?
- PureCycle: Up 250% in 2024 – Is This Materials Stock Still a Buy?
- Short Selling: How to Short a Stock
- MarketBeat Week in Review – 10/21- 10/25
Receive News & Ratings for 111 Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for 111 and related companies with MarketBeat.com's FREE daily email newsletter.